MedTrace Logo

Effect of Coffee Consumption on Pain and Intestinal Motility After Caesarean Section:

NCT06359223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-07-14

No results posted yet for this study

Summary

Objective The aim of this study was to investigate whether postoperative coffee intake affects pain levels and bowel motility in women undergoing cesarean delivery.

Design: It will be conducted as a randomized controlled experimental study. Method: It is a randomized controlled experimental study: This randomized controlled clinical trial will be conducted between May and December 2024 in accordance with the Consolidated Standards of Reporting Trials. A total of 60 women will be randomly assigned to the intervention group (n=30) or the control group (n=30). Participants in the intervention group will receive 100 mg caffeine in coffee at 6 and 12 hours after surgery in addition to routine postoperative care. The control group will receive only routine postoperative care. Pain will be assessed using Visual Analog Scale (VAS) and bowel activity will be monitored by time to first defecation, gas passage and bowel sounds.

Keywords: Caesarean section, Coffee, Pain, Motility

Conditions

  • Operation
  • Cesarean Section

Interventions

DIETARY_SUPPLEMENT

coffee consumption

After cesarean section, patients will be allowed to drink coffee.

OTHER

control group

Patients will undergo a routine surgical procedure.

Sponsors & Collaborators

  • KTO Karatay University

    collaborator OTHER

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • HÜMEYRA YÜKSEL, Phd · KTO Karatay University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-20
Primary Completion
2024-09-15
Completion
2024-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06359223 on ClinicalTrials.gov